MarketAxess Holdings Inc. (MKTX)

G1 Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	462.84	544.48	451.28	430.75	506.74	460.86
Trading Asset Securities	100.33	99.05	99.68	74.41	24.88	19.22
Cash & Short-Term Investments	563.16	643.52	550.96	505.16	531.62	480.08
Cash Growth	5.54%	16.80%	9.07%	-4.98%	10.73%	34.65%
Accounts Receivable	295.01	228.27	374.16	313.51	216.65	167.26
Other Receivables	237.84	113.65	288.46	152.36	187.02	95.19
Receivables	532.85	341.92	662.62	465.86	403.66	262.45
Prepaid Expenses	48.58	46.96	82.48	66.24	26.96	28.95
Restricted Cash	187.62	155.98	160.39	141.92	118.83	147.19
Other Current Assets	12.99	11.11	12.39	9.38	11.2	8.89
Total Current Assets	1,345	1,199	1,469	1,189	1,092	927.56
Property, Plant & Equipment	164.59	165.43	165.72	166.36	167.02	161.13
Long-Term Investments	57.74	89.51	24.69	-	-	-
Goodwill	286.02	236.71	236.71	154.79	154.79	147.39
Other Intangible Assets	121.4	98.08	119.11	98.07	116.38	95.35
Total Assets	1,975	1,789	2,015	1,608	1,530	1,331
Accounts Payable	28.28	31.3	32.47	37.25	48.72	44.35
Accrued Expenses	48.2	68.05	60.12	56.3	59.72	62.33
Current Portion of Leases	6.58	12.78	-	-	-	-
Current Income Taxes Payable	95.2	3.68	7.89	28.45	40.46	42.75
Other Current Liabilities	-	0.94	-	14.03	-	-
Total Current Liabilities	178.25	116.75	100.49	136.02	148.89	149.43
Long-Term Leases	62.68	59.96	79.68	82.68	88.43	93.61
Long-Term Unearned Revenue	3.32	5	4.54	3.99	-	-
Other Long-Term Liabilities	329.79	218.85	537.4	303.99	251.83	133.33
Total Liabilities	574.04	400.56	722.1	526.68	489.14	376.37
Common Stock	0.12	0.12	0.12	0.12	0.12	0.12
Additional Paid-In Capital	356.82	350.7	333.29	345.47	330.26	329.74
Retained Earnings	1,435	1,406	1,244	1,102	956.97	799.37
Treasury Stock	-407.03	-333.37	-260.3	-328.33	-232.71	-169.52
Comprehensive Income & Other	1.32	-34.7	-24.37	-37.7	-13.33	-4.65
Shareholders' Equity	1,401	1,389	1,293	1,081	1,041	955.06
Total Liabilities & Equity	1,975	1,789	2,015	1,608	1,530	1,331
Total Debt	69.26	72.74	79.68	82.68	88.43	93.61
Net Cash (Debt)	493.9	570.78	471.29	422.48	443.19	386.47
Net Cash Growth	7.99%	21.11%	11.55%	-4.67%	14.68%	49.47%
Net Cash Per Share	13.17	15.15	12.52	11.22	11.63	10.13
Filing Date Shares Outstanding	37.36	37.69	37.87	37.61	37.84	38
Total Common Shares Outstanding	37.42	37.65	37.9	37.65	37.92	38.01
Working Capital	1,167	1,083	1,368	1,053	943.37	778.13
Book Value Per Share	37.05	36.89	34.12	28.72	27.46	25.13
Tangible Book Value	978.77	1,054	937.15	828.24	770.14	712.32
Tangible Book Value Per Share	26.16	27.99	24.73	22.00	20.31	18.74
Machinery	-	64.49	57.03	53.02	61.97	68.56
Leasehold Improvements	-	31.39	31.21	30.66	31.02	29.06

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q